Discover
false
Chandreyee Das
Chandreyee Das, PhD, researches the needs of biomarker and biospecimen operations team working on precision medicine clinical trials. With more than 15 years of scientific communications experience, Chandreyee creates content that helps Sponsors navigate the path to better, faster decision-making through the use of technology solutions that she wishes she had during her time as an oncology researcher.
-
Read: Case Study: Global Phase 2 Drug Delivery in Advanced Colorectal Cancer
Case Study: Global Phase 2 Drug Delivery in Advanced Colorectal Cancer
-
Read: Case Study: Managing Complexity in an Autologous Cell Therapy Trial
Discover
-
Read: How Investigator Engagement Builds Enrollment Momentum
Discover
-
Read: Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs
Discover
-
Read: Has the rest of the world finally caught up with Latin America?
Discover
-
Read: Case Study: Rapid Execution of Assay Validation Rescued Global Study
DiscoverTranslational Research - Assays
Case Study: Rapid Execution of Assay Validation Rescued Global Study
| -
Read: Clinical AI at Scale: Why Trust Matters More Than Speed
Discover
-
Read: Hidden Strategic Edge in Clinical Trials: Financial Project Management
Discover
-
Read: Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence
DiscoverEarly Phase Research - Autoimmune
Why Most Early Autoimmune Trials Fail to Yield Decision-ready Evidence
|
Loading...
You've reach the end